Gene Ontology annotation through association of InterPro records with GO terms
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
Electronic Gene Ontology annotations created by ARBA machine learning models
Combined Automated Annotation using Multiple IEA Methods
Genomic characterization of the lysophosphatidic acid receptor gene, lp(A2)/Edg4, and identification of a frameshift mutation in a previously characterized cDNA.
-
Human and mouse LPAR2 transcripts are encoded by three exons, with an intron interrupting the region encoding transmembrane domain VI.
"Sequence analysis of genomic clones demonstrated that both mouse and human transcripts were encoded by three exons, with an intron separating the coding region for transmembrane domain VI."
-
The frameshift in the initially characterized human EDG4 cDNA was a tumor-derived sequence variant, not evidence for a normal LPAR2 protein isoform.
"One such variant (a G deletion) in the initially characterized Edg4 cDNA clone (derived from an ovarian tumor) results in a frameshift mutation near the 3' end of the coding region."
Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors.
-
Recombinant EDG4/LPAR2 responds broadly to LPA molecular species, while discriminating between shorter saturated acyl chains.
"In contrast, EDG2 and EDG4 showed broad ligand specificities, although EDG2 and EDG4 discriminated between 14:0 (myristoyl) and 16:0 (palmitoyl), and 12:0 (lauroyl) and 14:0 LPAs, respectively."
TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor.
-
LPA stimulation promotes a direct interaction between TRIP6 LIM domains and the LPAR2 carboxyl-terminal tail.
"Here we show that LPA stimulation promotes the interaction of the LPA(2) receptor with a focal adhesion molecule, TRIP6 (thyroid receptor interacting protein 6)/ZRP-1 (zyxin-related protein 1). TRIP6 directly binds to the carboxyl-terminal tail of the LPA(2) receptor through its LIM domains."
-
TRIP6 recruitment links activated LPAR2 to focal adhesions, actin stress fibers, and enhanced cell migration.
"Overexpression of TRIP6 augments LPA-induced cell migration; in contrast, suppression of endogenous TRIP6 expression by a TRIP6-specific small interfering RNA reduces it in SKOV3 ovarian cancer cells."
NHERF2 specifically interacts with LPA2 receptor and defines the specificity and efficiency of receptor-mediated phospholipase C-beta3 activation.
-
LPAR2 specifically binds NHERF2 through its C-terminal PDZ-binding motif and the second PDZ domain of NHERF2.
"This study found that LPA(2), but not the other LPA receptor isoforms, specifically interacts with Na(+)/H(+) exchanger regulatory factor2 (NHERF2). In addition, the interaction between them requires the C-terminal PDZ domain-binding motif of LPA(2) and the second PDZ domain of NHERF2."
-
NHERF2 scaffolds LPAR2 specifically to PLC-beta3 and potentiates receptor-driven PLC signaling.
"Using its second PDZ domain, NHERF2 was found to indirectly link LPA(2) to PLC-beta3 to form a complex, and the other PLC-beta isozymes were not included in the protein complex. Consistently, LPA(2)-mediated PLC-beta activation was specifically inhibited by the gene silencing of PLC-beta3."
Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions.
-
In intestinal epithelial cells, LPAR2 localizes apically and forms an NHERF2-mediated macromolecular complex with CFTR.
"Here we show, for the first time, that type 2 LPA receptors (LPA2) are expressed at the apical surface of intestinal epithelial cells, where they form a macromolecular complex with Na+/H+ exchanger regulatory factor-2 and CFTR through a PSD95/Dlg/ZO-1-based interaction."
-
LPAR2 signals through Gi to inhibit CFTR activity in a spatially compartmentalized epithelial membrane domain.
"LPA inhibited CFTR-dependent iodide efflux through LPA2-mediated Gi pathway, and LPA inhibited CFTR-mediated short-circuit currents in a compartmentalized fashion."
MAGI-3 regulates LPA-induced activation of Erk and RhoA.
-
MAGI3 binds LPAR2 specifically through its fifth PDZ domain and the receptor's terminal four residues.
"MAGI-3 specifically bound to LPA(2), but not to LPA(1) and LPA(3). This interaction was mediated via the fifth PDZ domain of MAGI-3 interacting with the carboxyl-terminal 4 amino acids of LPA(2), and mutational alteration of the carboxyl-terminal sequences of LPA(2) severely attenuated its ability to bind MAGI-3."
-
MAGI3 promotes LPAR2-linked ERK and RhoA activation in SW480 colon cancer cells.
"These results demonstrate that MAGI-3 interacts directly with LPA(2) and regulates the ability of LPA(2) to activate Erk and RhoA."
Dual regulation of lysophosphatidic acid (LPA1) receptor signalling by Ral and GRK.
-
RalA associates with both LPAR1 and LPAR2 in HEK293 cells, but the accessible evidence assigns LPA-triggered RalA activation specifically to LPAR1.
"We show that the small GTPase RalA associates with both LPA(1) and LPA(2) in human embryonic kidney (HEK 293) cells and that stimulation of LPA(1) receptors with LPA triggers the activation of RalA."
-
GRK2 is required for desensitization of both LPAR1 and LPAR2.
"Furthermore, we found that GRK2 is required for the desensitization of LPA(1) and LPA(2) and have identified a novel interaction between RalA and GRK2, which is promoted by LPA(1) receptor activity."
Architecture of the human interactome defines protein communities and disease networks.
-
BioPlex 2.0 is a large-scale human affinity-purification mass-spectrometry interaction map rather than a targeted LPAR2 mechanistic study.
"Here we present BioPlex 2.0 (Biophysical Interactions of ORFeome-derived complexes), which uses robust affinity purification-mass spectrometry methodology to elucidate protein interaction networks and co-complexes nucleated by more than 25% of protein-coding genes from the human genome, and constitutes, to our knowledge, the largest such network so far."
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
-
BioPlex 3.0 provides cell-line-specific AP-MS interaction networks and shows that interaction context can differ between cell lines.
"Through affinity-purification mass spectrometry, we have created two proteome-scale, cell-line-specific interaction networks."
Multiplexed mapping of the interactome of GPCRs with receptor activity-modifying proteins.
-
LPAR2 showed strong evidence for complex formation with RAMP1, RAMP2, and RAMP3 across all capture-detection methods in the heterologous screen.
"Nine GPCRs showed evidence for complex formation with all three RAMPs across all capture-detection methods: GABBR1, GPR143, GPR21, GPR61, HTR4, LPAR2, MTNR1A, OXER1, and P2RY11 (see table S1 for the corresponding GPCR UniProt IDs)."
Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid.
-
Human EDG4/LPAR2 expression confers concentration-dependent, LPA-specific signaling and increases specific radiolabeled-LPA binding sites.
"When overexpressed in Jurkat T cells, the Edg4 protein mediated LPA-induced activation of a serum response element reporter gene with LPA concentration dependence (EC50 of 10 nM) and specificity."
-
The founding receptor assay supports both pertussis-toxin-sensitive Gi input and Rho-dependent signaling downstream of LPAR2.
"This LPA-induced reporter gene activation could be partially inhibited by pretreatment with pertussis toxin or C3 exoenzyme, suggesting requirements for both a Gi protein and Rho GTPase."
-
Two differently distributed EDG4 mRNA sizes were observed, but the abstract does not establish distinct protein isoforms.
"Northern blots revealed that two edg4 mRNA transcripts of 1.8 and 8 kilobases are distributed very differently from edg2 mRNAs in adult human tissues and several cancer cell lines."
Recombinant human G protein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization.
-
Recombinant human EDG4/LPAR2 mobilizes calcium through PLC-generated IP3.
"The coincident production of inositol phosphates and the inhibition of Ca2+ mobilization by the phospholipase C inhibitor U73122 strongly suggested that Edg2 and Edg4 mobilize Ca2+ through inositol trisphosphate generated by phospholipase C activation."
-
LPAR2 calcium mobilization requires both pertussis-toxin-sensitive Gi and Gq inputs.
"Pertussis toxin almost completely blocked LPA-induced Ca2+ mobilization by Edg2 but only partially blocked that by Edg4, which suggests that Edg2 transduces Ca2+ mobilization largely through pertussis toxin-sensitive Gi proteins, whereas Edg4 requires both Gi and Gq."
Liganded Gq/11-activating GPCRs act as GEFs for Gq/11
-
Reactome models Gq/11 activation as driving PLC, IP3/DAG production, and increased cytosolic calcium.
"PLC hydrolyzes phosphatidylinositol (PIP2) to diacyl glycerol (DAG) and inositol triphosphate (IP3)."
Liganded Gi-activating GPCR acts as a GEF for Gi
-
Reactome models a liganded Gi-coupled GPCR as catalyzing GDP-GTP exchange on the G-alpha subunit.
"This stimulates the exchange of GDP for GTP in the G-protein alpha subunit, activating the G-protein."
LPA-binding receptors bind LPA
-
Reactome identifies human EDG4 as LPAR2 and links its LPA-dependent calcium mobilization to Gi and Gq.
"EDG4 is a human gene which encodes the GPCR known as LPA2 (An S et al, 1998). This protein contributes towards Ca2+ mobilization, a critical cellular response to LPA in cells, through association with Gi and Gq proteins (An S et al, 1998)."
Liganded Gq-activating GPCRs bind inactive heterotrimeric Gq
The Ligand:GPCR:Gq complex dissociates
The Ligand:GPCR:Gi complex dissociates
Liganded Gi-activating GPCRs bind inactive heterotrimeric G-protein Gi
-
Reactome models Gi alpha as inhibiting cAMP production and thereby reducing PKA activity.
"The G-alpha (i) subunit inhibits the production of cAMP from ATP. In turn, this results in decreased activity of cAMP-dependent protein kinase."
UniProtKB record for human LPAR2 (Q9HBW0)
-
UniProt summarizes LPAR2 coupling to G12/G13 and Gq-family heterotrimeric G proteins.
"G(12)/G(13), and G(q) families of heteromeric G proteins. Plays a key"
-
UniProt records LPAR2 colocalization with RalA in endocytic vesicles.
"colocalizes with RALA in the endocytic vesicles."
Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid.
Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate.
Phosphorylation and Internalization of Lysophosphatidic Acid Receptors LPA1, LPA2, and LPA3.